[Pe-054] Neuroimmunology (immune-mediated encephalitis3)

[Pe-054-3] Differences in clinical features between NMDA vs AMPA type anti-glutamate receptor encephalitis

Kimihiko Kaneko^1,2, Douglas Sato^2,3, Toshiyuki Takahashi^2,4, Naoko Nakamura², Ryo Ogawa², Yoshiki Takai², Shuhei Nishiyama², Hiroshi Kuroda², Tatsuro Misu², Kazuhiro Kato⁵, Yasushi Suzuki⁶, Juichi Fujimori⁷, Ichiro Nakashima^2,7, Kazuo Fujihara^2,8,9, Masashi Aoki² (1.Department of Neurology, NHO Miyagi Hospital, Japan, 2.Department of Neurology, Tohoku University Hospital, Japan, 3.Brain Institute and Hospital Sao Lucas, Pontifical Catholic University of Rio Grande do Sul, Brazil, 4.Department of Neurology, NHO Yonezawa Hospital, Japan, 5.Department of Neurology, Ishinomaki Red Cross Hospital, Japan, 6.Department of Neurology, Sendai Medical Center, Japan, 7.Department of Neurology, Tohoku Medical and Pharmaceutical University Hospital, Japan, 8.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 9.Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan)